Correlation Between Dermata Therapeutics and ProQR Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and ProQR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and ProQR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics and ProQR Therapeutics BV, you can compare the effects of market volatilities on Dermata Therapeutics and ProQR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of ProQR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and ProQR Therapeutics.
Diversification Opportunities for Dermata Therapeutics and ProQR Therapeutics
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Dermata and ProQR is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and ProQR Therapeutics BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProQR Therapeutics and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with ProQR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProQR Therapeutics has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and ProQR Therapeutics go up and down completely randomly.
Pair Corralation between Dermata Therapeutics and ProQR Therapeutics
Given the investment horizon of 90 days Dermata Therapeutics is expected to under-perform the ProQR Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Dermata Therapeutics is 1.88 times less risky than ProQR Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The ProQR Therapeutics BV is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 192.00 in ProQR Therapeutics BV on September 3, 2024 and sell it today you would earn a total of 192.00 from holding ProQR Therapeutics BV or generate 100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dermata Therapeutics vs. ProQR Therapeutics BV
Performance |
| Timeline |
| Dermata Therapeutics |
| ProQR Therapeutics |
Dermata Therapeutics and ProQR Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dermata Therapeutics and ProQR Therapeutics
The main advantage of trading using opposite Dermata Therapeutics and ProQR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, ProQR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProQR Therapeutics will offset losses from the drop in ProQR Therapeutics' long position.| Dermata Therapeutics vs. DiaMedica Therapeutics | Dermata Therapeutics vs. Lyra Therapeutics | Dermata Therapeutics vs. Centessa Pharmaceuticals PLC |
| ProQR Therapeutics vs. Annexon | ProQR Therapeutics vs. Arrowhead Pharmaceuticals | ProQR Therapeutics vs. Day One Biopharmaceuticals | ProQR Therapeutics vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |